Important note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.
 |
Associated Press - March 29, 2004
The study is a joint effort by Cambodia's Health Ministry, the University of California in San Francisco and Australia's University of New South Wales.
The Bill & Melinda Gates Foundation is funding the study under a program to test the tenofovir DF drug in several nations and find out if it reduces the HIV infection risk among sexually active adults regularly exposed to the virus.
The drug is already used to treat people infected with the AIDS-causing virus. The new tests are aimed at determining if the drug can prevent infection in those who don't have HIV.
But 150 Cambodian sex workers belonging to a group called Women's Network for Unity said they'd only take part if given insurance to treat possible side effects for 30 years.
"Now I'm still beautiful, and I can't make a joke of my future. Who will be responsible if my health fails after the test?" said Ly Linda, a 32-year-old prostitute.
"No, I will not join in the test," she said to applause from colleagues meeting on Monday over the insurance issue. A banner at the meeting read:
"Without life insurance, please take the drug back for trial in America."
Kimberly Page Shafer, a University of California professor who attended the meeting, said the drug's side effects aren't serious, and include stomach gas and nausea. Women will be provided medical care for side effects during and after the trial period, she said.
The U.S. health department says the side effects - when the drug is taken as an HIV treatment - range from diarrhea and rashes to liver or kidney failure.
Shafer told The Associated Press after the meeting that it was impossible to provide insurance.
"There's probably no place in the world where women in clinical trial have access to coverage for life. So I have to decide if I want to work on insurance coverage or on HIV prevention," she said.
Cambodia was chosen for the study because of its high rate of HIV infection, said Khol Vohith, a researcher at the country's National Center for HIV/AIDS and Sexually Transmitted Diseases.
Cambodia has Southeast Asia's highest HIV infection rate, though this has dropped to 2.6% in 2002 from 3.8% in 1997.
Shafer said she hopes that enough women will join the study. She wouldn't say how many have already been recruited.
-Edited by Sarah C. de Mesa
040329
AP040359
Copyright © 2004 - Associated Press. Reproduction of this article (other than one copy for personal reference) must be cleared through the AP Permissions Desk.
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .